Givinostat Conditionally Approved to Treat Patients with Duchenne Muscular Dystrophy (DMD)
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (20 December 2024) granted a conditional marketing authorisation...
What do you think?
Log in to reply to this SHMOOZ post.
There are no replies yet.